BioMin Technologies Ltd was established in 2014 to commercialize research conducted over the past decade at Queen Mary University London and Imperial College, London, to develop bioactive glass materials for treating dentine hypersensitivity, promoting remineralisation and preventing tooth decay. BioMin’s technology received the 2013 Worshipful Company Armourers and Brasiers’ Venture Prize for innovation. BioMin’s technology is based on two key patent applications.